IFM Continua
Boston, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into IFM Continua
Sign up to see every warm intro you have to IFM Continua
- Paths you didn't know you had: your email and LinkedIn already hold routes to the IFM Continua team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JL
John LeonardNamed on SEC filing
GG
Gary GlickNamed on SEC filing
SC
Shelley ChuNamed on SEC filing
Board
JF

Investors · 1
Reported raises · per SEC filings
Form D private placements$350K disclosed across 1 round · 2019
▶$350KraisedDec 2019 · 2 investors · BiotechnologyRule 506(b)
▶$350KraisedDec 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Francois FormelaDirector
- John LeonardDirector
- Gary GlickExecutive Officer, Director
- Shelley ChuDirector
- Amount sold
- $350K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are IFM Continua's investors?
- IFM Continua's investors include Atlas Venture.
- How much funding has IFM Continua raised?
- IFM Continua has disclosed $350K raised across 1 round.
- Where is IFM Continua headquartered?
- IFM Continua is headquartered in Boston, US.